CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 113 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $108,000 | +285.7% | 59,269 | +307.0% | 0.00% | – |
| Q1 2021 | $28,000 | +33.3% | 14,562 | -16.1% | 0.00% | – |
| Q4 2020 | $21,000 | -98.4% | 17,349 | -97.6% | 0.00% | -100.0% |
| Q3 2020 | $1,324,000 | +28.7% | 735,920 | +500.2% | 0.00% | 0.0% |
| Q2 2020 | $1,029,000 | +208.1% | 122,608 | +92.4% | 0.00% | – |
| Q1 2020 | $334,000 | +413.8% | 63,739 | +373.9% | 0.00% | – |
| Q3 2019 | $65,000 | -40.4% | 13,449 | -14.4% | 0.00% | – |
| Q2 2019 | $109,000 | +10.1% | 15,720 | +11.6% | 0.00% | – |
| Q1 2019 | $99,000 | +25.3% | 14,092 | +33.9% | 0.00% | – |
| Q3 2018 | $79,000 | +8.2% | 10,525 | -27.8% | 0.00% | – |
| Q2 2018 | $73,000 | -53.2% | 14,582 | -42.7% | 0.00% | – |
| Q1 2018 | $156,000 | -72.2% | 25,460 | -67.8% | 0.00% | -100.0% |
| Q4 2017 | $562,000 | +171.5% | 79,075 | +172.7% | 0.00% | – |
| Q3 2017 | $207,000 | +31.8% | 28,993 | +52.6% | 0.00% | – |
| Q1 2017 | $157,000 | – | 18,998 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $6,307,000 | 4.30% |
| ETF MANAGERS GROUP, LLC | 8,103,641 | $10,130,000 | 0.22% |
| AdvisorShares Investments LLC | 271,873 | $340,000 | 0.08% |
| Platform Technology Partners | 60,000 | $75,000 | 0.04% |
| PINNACLE ASSOCIATES LTD | 942,079 | $1,178,000 | 0.02% |
| HRT FINANCIAL LP | 883,510 | $1,104,000 | 0.02% |
| Virtu Financial LLC | 153,908 | $192,000 | 0.02% |
| Tekla Capital Management LLC | 413,481 | $517,000 | 0.02% |
| Aries Wealth Management | 23,400 | $33,000 | 0.02% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 56,932 | $71,000 | 0.02% |